Sage Therapeutics, Inc. 4
4 · Sage Therapeutics, Inc. · Filed Nov 28, 2016
Insider Transaction Report
Form 4
Anderson Thomas
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2016-11-15$8.92/sh+10,000$89,200→ 10,000 total - Sale
Common Stock
2016-11-15$55.00/sh−10,000$550,000→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-11-15−10,000→ 167,038 totalExercise: $8.92Exp: 2024-05-21→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2015 Stock Option and Incentive Plan. The option shall vest in full on May 5, 2018, subject to continued service through such date.